Clinical trials
PARKINSON DISEASE (Disorder) clinical trials
Below are recruiting parkinson disease (disorder) clinical trials, each written for real people, not researchers. We’re tracking 497 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06634641RecruitingPhase 4
Clozapine and immune function in Parkinson's disease
This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.
SalouëlAges 18 years+ - NCT06665113Recruiting
Ear nerve stimulation for early Parkinson's disease
This trial tests whether a non-invasive nerve stimulation device (taVNS) worn on the ear can protect brain cells and slow Parkinson's disease progression in early-stage patients. It is for people who have been diagnosed within the last 3 years and are already on standard medication.
Nanjing, JiangsuAges 55–75 - NCT01682668Recruiting
Deep brain stimulation study for Parkinson movement problems
This study looks at how deep brain stimulation (an implanted brain device) affects Parkinson’s symptoms, especially movement problems like freezing, slowness, or involuntary movements. It may help people whose symptoms are not fully controlled by standard Parkinson medicines.
Paris, PARISAges 18–70 - NCT06753331RecruitingPhase 1/Phase 2
Study of DSP-1083 for Parkinson's disease
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
Lexington, KentuckyAges 40–72 - NCT06804642Recruiting
Spinal cord stimulation for Parkinson's walking rehab
This study tests whether a mild electrical stimulation applied to the skin on your lower back (called spinal cord stimulation) can help improve walking and movement in people with Parkinson's disease. It involves some rehabilitation exercises, and the goal is to see if this combination can help you move better.
Louisville, KentuckyAges 18–80 - NCT06874803Recruiting
Acupuncture and moxibustion for early Parkinson's motor symptoms
This trial tests whether acupuncture and moxibustion can help improve movement symptoms in people with early to moderate Parkinson's disease. It is designed to see if adding these treatments to your regular care offers extra benefits.
Beijing, Beijing MunicipalityAges 30–80 - NCT07105787Recruiting
Parkinson's exercise study: Tel Aviv and Bologna
This trial tests whether a specific exercise program can improve walking and movement in people with early to moderate Parkinson's disease. If you have trouble with your gait or balance, this study may offer a supervised exercise program to help manage symptoms.
Tel AvivAges Any age - NCT07170475RecruitingPhase 1
Study of febuxostat and inosine for Parkinson's disease
This trial tests whether a combination of two supplements, febuxostat and inosine, can help people with Parkinson's disease. It aims to see if this treatment is safe and may improve symptoms.
Toyoake, Aichi-kenAges 18–80 - NCT07216066RecruitingPhase 1
Study of ALN-SNCA for early Parkinson's disease
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Montreal, QuebecAges 50–80 - NCT07244640Recruiting
Detecting Parkinson's through eye scans
This study uses a special eye camera to see if early signs of Parkinson's and similar movement disorders can be spotted in the retina. It may help doctors diagnose these conditions sooner and more easily.
Hangzhou, ZhejiangAges 40–80 - NCT07310147Recruiting
Online ACT therapy for young-onset Parkinson’s
This trial tests an online program based on Acceptance and Commitment Therapy (ACT) to help people with young-onset Parkinson’s disease cope better with life challenges. It aims to improve emotional well-being and quality of mind.
CoimbraAges 21–65 - NCT05901818RecruitingPhase 1
Testing a patient’s own stem-cell treatment for Parkinson’s
This Phase 1 study tests whether an “autologous” (from your own body) iNSC-DAP stem-cell treatment is safe and may help symptoms in Parkinson’s disease. It is designed mainly to check safety, while also watching for signs of improvement.
Beijing, Beijing MunicipalityAges 30–85 - NCT07378722Recruiting
Personalized music therapy for balance in Parkinson's disease
This study tests whether listening to personalized music can help improve balance and walking in people with Parkinson's. If you have mild balance issues and are between 45 and 55, this trial might be a good fit.
Lahore, Punjab ProvinceAges 45–55 - NCT07397377Recruiting
Brain stimulation for slow movement in Parkinson's
This study tests whether a gentle form of brain stimulation (called prTMS) can help improve slow movement in people with Parkinson's. You would come to the Danish Research Centre for Magnetic Resonance for several sessions. The goal is to see if this non-invasive treatment can make daily tasks a bit easier.
HvidovreAges 18–80 - NCT07403539Recruiting
Speech learning and production in Parkinson's disease
This study looks at how people with Parkinson's disease learn and produce speech. It may help researchers understand how Parkinson's affects talking and how to improve communication.
Buffalo, New YorkAges 45 years+ - NCT07485621Recruiting
Using brain signals to improve deep brain stimulation for Parkinson's
This study uses brain signals (called local field potentials) from the deep brain stimulation (DBS) device to see if they can predict how well the treatment is working. It aims to help doctors adjust DBS settings more precisely for people with Parkinson's disease.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06671600Recruiting
Osteopathic treatment for sleep in Parkinson's disease
This study tests if gentle hands-on treatments (osteopathic manipulative medicine) can improve sleep quality for people with Parkinson's disease. You will wear a Fitbit and a ring to track your sleep, and receive the treatments over several sessions.
Old Westbury, New YorkAges Any age - NCT07536022Recruiting
At-Home Ear Stimulation for Walking and Balance in Parkinson's
This study tests a small device worn on your ear (called taVNS) that sends mild electrical signals to help improve walking and balance problems in Parkinson's disease. You'll use it at home, and researchers will track whether it helps you move better.
Charleston, South CarolinaAges 40–85 - NCT07567482Recruiting
Exoskeleton-Assisted Walking for Parkinson's and Aging
This study tests whether a wearable robotic exoskeleton (a powered leg device) can help people with Parkinson's disease and older adults walk better and stay active. Researchers want to see if this technology improves mobility and reduces fall risk.
Gatineau, QuebecAges 50 years+ - NCT07569133Enrolling by invitation
Brain Stimulation to Reduce Depression in Parkinson's Disease
This study tests whether repetitive transcranial magnetic stimulation (rTMS)—a non-invasive brain stimulation technique—can safely reduce depressive symptoms in people with Parkinson's disease. If it works, it could offer a new treatment option for depression that often accompanies Parkinson's.
Daegu, Buk-guAges 40–90 - NCT06641193Enrolling by invitation
rTMS for arm slowness in early Parkinson's
This trial tests a brain stimulation technique called rTMS to see if it can help improve slowness of movement in the arm and hand. It's for people with early-stage Parkinson's whose symptoms started on the left side and whose main problem is moving slowly.
Shanghai, ChinaAges 50–75 - NCT05573542Enrolling by invitation
Study early Parkinson signs in people with IBS
This study looks for early clues of Parkinson’s disease in people who have IBS (irritable bowel syndrome), and compares them with people without IBS. The goal is to understand whether gut symptoms or test results can help spot Parkinson’s earlier.
ÖrebroAges 18–85 - NCT06596746Recruiting
Tracking markers for neurodegenerative diseases
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Cassino, FrosinoneAges 10 years+ - NCT06088121Recruiting
TMS with cognitive training for mild Alzheimer's dementia
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
Incheon, Bupyeong 6(yuk)-dong, Bupyeong-guAges 60–85
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease (disorder)?
- Yes. Clin2 currently lists 497 recruiting parkinson disease (disorder) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease (disorder) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease (disorder) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.